Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunophenotypic characterization of myelopoiesis in early and late myelodysplastic syndromes: use of CD44 as an aid in early diagnosis.

Cytometry - 15 Aug 2002

Karmon Yuval, Manaster J, Chezar J

Abstract excerpt

We investigated the possibility that myeloid cells from the bone marrow (BM) of myelodysplastic patients differ in their expression of CD44 antigen compared with expression of the antigen in normal controls. In addition, two triple-surface marker assays incorporating, respectively, CD44/CD33/CD66 and CD33/CD34/HLA-DR were used to evaluate the degree of myeloid maturation and assess the number of blasts in BM by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Antigens, Differentiation
Share to Antigens, Surface

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Bone Marrow Diseases

Share to Cell Adhesion Molecules

Share to Hyaluronan Receptors

Share to Myeloid Cells

Share to Myelopoiesis

Source

Identifiers

PMID: 12210602
DOI: 10.1002/cyto.10110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunophenotypic characterization of myelopoiesis in early and late myelodysplastic syndromes: use of CD44 as an aid in early diagnosis.PMID 12210602Read ↗

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursorsSemantic proximity Read ↗

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionSemantic proximity Read ↗

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeSemantic proximity Read ↗

Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.Semantic proximity Read ↗

A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMMLSemantic proximity Read ↗

Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia.Semantic proximity Read ↗

Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common.Semantic proximity Read ↗

The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes.Semantic proximity Read ↗

Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.Semantic proximity Read ↗

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Detection of molecular targets on the surface of CD34<sup>+</sup>CD38<sup>−</sup> bone marrow cells in myelodysplastic syndromesSemantic proximity Read ↗

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.